Basis: Current FMP quote-based enterprise value / four-quarter revenue. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/Sales ratio is N/A as of 2026-10-06T15:41:49.495Z.
Calculation as of: 2026-10-06T15:41:49.495Z.
Quote observation: 2026-10-06T15:39:11.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: f130e36c5816a2cced4d00ccb7d778b7baaa6bfdcaf5b95b3974dc9f748ee68d
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/SALES RATIO
N/A
FibroBiologics, Inc. Common Stock
Market Cap
$2.58M
EV/Sales Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.55M
EV/Sales Ratio
0.26x
TTM Avg
0.39x
3Y Avg
13.04x
5Y Avg
1086.20x
Market Cap
$2.33M
EV/Sales Ratio
N/A
TTM Avg
405.75x
3Y Avg
236.64x
5Y Avg
99422.58x
| NAME | MARKET CAP | EV/SALES RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| FibroBiologics, Inc. Common Stock (FBLG) | $2.58M | N/A | N/A | N/A | N/A |
| bioAffinity Technologies, Inc. (BIAF)vs › | $2.55M | 0.26x | 0.39x | 13.04x | 1086.20x |
| Nuwellis, Inc. (NUWE)vs › | $2.63M | N/A | 3.25x | 6.72x | 22.50x |
| Jaguar Health, Inc. (JAGX)vs › | $2.46M | 0.45x | 2.11x | 2.56x | 2.95x |
| iSpecimen Inc. (ISPC)vs › | $2.64M | N/A | 0.22x | 0.27x | 1.10x |
| Moleculin Biotech, Inc. (MBRX)vs › | $2.45M | N/A | N/A | N/A | N/A |
| Creative Medical Technology Holdings, Inc. (CELZ)vs › | $2.33M | N/A | 405.75x | 236.64x | 99422.58x |
| Onconetix, Inc. (ONCO)vs › | $2.32M | N/A | 187.46x | 673.37x | 673.37x |
| GeoVax Labs, Inc. (GOVX)vs › | $2.27M | N/A | 1.51x | 4.91x | 63.51x |
| Adagio Medical Holdings, Inc. (ADGM)vs › | $3.04M | N/A | 126.62x | 132.74x | 132.74x |
Enterprise Value (EV) = Market Cap + Total Debt - Cash
Sales = Total Revenue (TTM)
EV/Sales is commonly used because:
Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.
EV/Sales = Enterprise Value / Revenue (TTM)
Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
